Methylenetetrahydrofolate reductase polymorphism (677 C>T) predicts long time to progression in metastatic colon cancer treated with 5-fluorouracil and folinic acid.

Source:http://linkedlifedata.com/resource/pubmed/id/21044746

Download in:

View as

General Info

PMID
21044746